Intrinsic Value of S&P & Nasdaq Contact Us

Jasper Therapeutics, Inc. JSPR NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
53/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$41.67
+4369.1%

Stock Statistics — JSPR

Jasper Therapeutics, Inc. (JSPR) has a market capitalization of $15.15M and trades at $0.93. The 52-week range is 0.686-7.19.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.2, Earnings Per Share (EPS) of $-3.95.

The stock has a beta of 3.09, operates in the Healthcare sector.

Trading Data
Current Price$0.93
52-Week Range0.686-7.19
Volume532.1K
Avg Volume (30D)500.18K
Market Cap$15.15M
Beta (1Y)3.09
Company
IPO Date2020-01-10
Employees64
CEOJeetinder Singh Mahal
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS4718712023
CUSIP471871103
Income (Latest Year)
EBITDA$-82.83M
Operating Income$-83.88M
Net Income$-75.8M
EPS$-3.95
EPS Diluted$-3.95
Shares Outstanding$19.17M
Balance Sheet (Latest Year)
Total Assets$35.78M
Current Assets$34.65M
Cash & ST Investments$28.69M
Total Liabilities$31.63M
Total Debt$1.24M
Net Debt$-27.46M
Total Equity$4.15M
Debt / Equity0.30
Valuation Ratios
P/E Ratio-0.2
P/B Ratio3.65
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message